| Cervical cancer worldwide |
36 |
| Chemotherapy and targeted therapy in the management of cervical cancer |
20 |
| HPV: Molecular pathways and targets |
14 |
| Hepatocellular carcinoma in the era of immunotherapy |
13 |
| HPV vaccination and the effects on rates of HPV-related cancers |
12 |
| The role of cardiac biomarkers in cardio-oncology |
10 |
| The significant prognostic value of circulating tumor cells in colorectal cancer: A systematic review and meta-analysis |
10 |
| HER2: An emerging target in colorectal cancer |
9 |
| The impact of microsatellite stability status in colorectal cancer |
9 |
| Adipocytokines and breast cancer |
9 |
| The role of epigenetic therapies in colorectal cancer |
8 |
| The possible role of insulin-like growth factor-1 in osteosarcoma |
8 |
| Cardiotoxicities associated with immune checkpoint inhibitors |
8 |
| Cardiovascular effects of radiation therapy |
7 |
| Squamous cell carcinoma of the anal canal |
7 |
| Management of cervical premalignant lesions |
7 |
| Clinical evaluation of carcinoembryonic and carbohydrate antigens as cancer biomarkers to monitor palliative chemotherapy in advanced stage gastric cancer |
7 |
| Association of elevated levels of C-reactive protein with breast cancer, breast cancer subtypes, and poor outcome |
6 |
| Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels |
5 |
| Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment |
5 |
| Update on primary HPV screening for cervical cancer prevention |
5 |
| Gearing up T-cell immunotherapy in cervical cancer |
5 |
| Expressional analysis of MLH1 and MSH2 in breast cancer |
5 |
| Clinicopathologic significance of LAIR-1 expression in hepatocellular carcinoma |
5 |
| Comparison of CA HE and ROMA index for ovarian cancer diagnosis |
4 |
| Durvalumab: a newly approved checkpoint inhibitor for the treatment of urothelial carcinoma |
4 |
| Future directions in soft tissue sarcoma treatment |
4 |
| The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma |
4 |
| Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future |
4 |
| Role of rebiopsy in metastatic breast cancer at progression |
3 |
| Yes-associated protein expression in paired primary and local recurrent breast cancer and its clinical significance |
3 |
| Controlling Nutritional Status score: A new prognostic indicator for patients with oligometastatic prostate cancer |
3 |
| Advanced imaging modalities to detect cardiotoxicity |
3 |
| Axillary web syndrome: Incidence, pathogenesis, and management |
3 |
| Comparative effectiveness study of single high-dose cisplatin with fractionated doses cisplatin in first-line therapy for treatment-naive Chinese patients with advanced non-small-cell lung cancer |
3 |
| Diagnostic classification of soft tissue malignancies: A review and update from a surgical pathology perspective |
3 |
| Uterine sarcomas |
3 |
| Encapsulated papillary carcinoma of the breast: A clinicopathological study of 49 cases |
3 |
| Risk factors for prostate cancer: A multifactorial case-control study |
3 |
| Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non-small cell lung cancer and their family caregivers |
3 |
| IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: The potential role of tumor infiltrated macrophages |
3 |
| BRCA1 mutation spectrum, functions, and therapeutic strategies: The story so far |
3 |
| Role of liquid biopsies in colorectal cancer |
3 |
| Factors associated with optimal pain management in advanced cancer patients |
3 |
| Everolimus plus endocrine vs endocrine therapy in treatment advanced ER+, HER2-breast cancer patients: A meta-analysis |
2 |
| Association of lymphadenectomy and survival in epithelial ovarian cancer |
2 |
| Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma |
2 |
| Polymorphism rs3819102 in thymidylate synthase and environmental factors: effects on lung cancer in Chinese population |
2 |
| Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients |
2 |
| Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis |
2 |
